Clinical Trial Update: Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing pemetrexed-based regimens with two-comparator regimens in first-line colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED